Neurologic Disorders Resource Center

Click on the subcategory below to find drug monographs for that particular area.

Miss AAN 2016?

You can still read all the top news from AAN 2016 here!

Metformin, Pioglitazone May Benefit MS Patients ...

Metformin and pioglitazone showed anti-inflammatory effects in patients with multiple sclerosis and metabolic syndrome, according to a new study published in JAMA Neurology.

Some Parkinson's Disease Meds May Up ...

Neurologists have linked medications used for Parkinson's disease with impulse control disorders such as pathological gambling, compulsive buying, hypersexuality, and binge eating in some patients.

Antipsychotic Use May Double Mortality Risk ...

According to a study in JAMA Neurology, antipsychotic use was associated with a significantly increased mortality risk in patients with Parkinson's disease (PD).

Lamotrigine Monotherapy in Epilepsy: What's the ...

A new study analysis suggests that for patients taking the antiepileptic drug (AED) lamotrigine as monotherapy, escalating dosage from the start of treatment may result in better efficacy.

Does Lamotrigine Use in Pregnancy Up ...

According to a study published in Neurology, babies born to pregnant women taking lamotrigine may not be at an increased risk of birth defects, such as a cleft lip, cleft palate or clubfoot.

Cholesterol: Protective Effect in MS?

Serum cholesterol may have a protective effect in multiple sclerosis (MS) via the blood-brain barrier, although researchers are unsure as to the mechanism of action.

News

Ext-Rel Molindone Linked to Reduced Aggression in Children With ADHD

An extended release formulation of molindone shows promise as an adjunctive treatment for refractory impulsive aggression among children administered stimulant monotherapy for ADHD.

Glatiramer Acetate to Fingolimod Switch Might Reduce MS Relapse Rates

Patients with relapsing-remitting multiple sclerosis (MS) had fewer relapses after switching from glatiramer acetate to fingolimod versus remaining on the injectable disease-modifying therapy

Higher Rates of Total Migraine Freedom Observed with Intranasal vs. Oral Sumatriptan

Treatment of acute migraine with AVP-825, an investigational Breath-Powered Bi-Directional intranasal delivery system containing sumatriptan powder 22mg, resulted in higher rates of total migraine freedom.

Study Supports Fingolimod Use vs. iDMTs in Early Relapsing-Remitting MS

The advantages of fingolimod over injectable disease-modifying therapies (iDMTs) in patient retention and treatment satisfaction support use of fingolimod in early relapsing-remitting multiple sclerosis (MS) in the real world.

FEATURES

A Disabling Side Effect of SSRI Therapy?

A Disabling Side Effect of SSRI Therapy?

Dysgraphia after sertraline intake has been documented in a case report published online in the Journal of Clinical Pharmacy and Therapeutics.

Interventions to Enhance Adherence to MS Therapies

Interventions to Enhance Adherence to MS Therapies

Multiple sclerosis (MS) is a challenging disease characterized by often debilitating symptoms, including pain, fatigue, cognitive impairment, sensorimotor deficits, bowel, and bladder problems, and mental health issues.

Yoga and Acupuncture: Helpful Adjuncts for MS Patients?

Yoga and Acupuncture: Helpful Adjuncts for MS Patients?

Yoga and acupuncture are two modalities commonly used by patients with MS. This article examines the potential benefits and risks of each.

Featured courses from mycme

Comprehensive Review of NeurologyExternal web site

Keep on top of this rapidly evolving specialty area and improve assessment and ...

CME 41.50 Credits

Stroke Risk After TIA Slashed in Last Decade?External web site

Among the many issues clinicians face today, staying current with advances in medicine is becoming ...

CME|CE 0.25 Credits

Stroke Rounds: Stroke, MI Risk Higher After DrinkingExternal web site

Among the many issues clinicians face today, staying current with advances in medicine is becoming ...

CME|CE 0.25 Credits

Sign Up for Free e-newsletters